Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized double-blind placebo-controlled two-way study of fluticasone furoate in pediatric asthma
2012-000753-31Phase 2
- Sponsor
- GSK
- Start
- Mar 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of fluticasone in asthma (2 arms), sponsored by GSK. Primary endpoint: Adverse events.
02
Drugs
fluticasone
03
Conditions
asthma
Beyond the preview
Go deeper on 2012-000753-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000753-31.